Sunshine Biopharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Sunshine Biopharma, Inc. (SBFM) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents9.6916.2921.832.050.99
Short-Term Investments0.000.000.000.010.01
Cash & Short-Term Investments9.6916.2921.832.051.00
Accounts Receivable3.872.551.910.010.00
Inventory11.285.733.290.110.02
Other Current Assets1.130.310.280.030.00
Total Current Assets25.9724.8927.312.201.03
Non-Current Assets
Property, Plant & Equipment (Net)1.481.011.150.010.02
Intangible Assets3.021.440.780.000.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets4.592.461.930.010.00
Total Assets30.5627.3529.242.201.05
Current Liabilities
Accounts Payable5.542.592.800.040.06
Short-Term Debt0.210.003.630.000.82
Current Portion of Long-Term Debt0.000.000.000.000.82
Accrued Liabilities0.000.000.000.050.02
Other Current Liabilities0.302.553.630.000.00
Total Current Liabilities6.315.556.930.091.05
Non-Current Liabilities
Long-Term Debt0.740.540.641.900.95
Deferred Tax Liabilities0.000.050.040.000.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.740.590.691.900.00
Total Liabilities7.066.147.621.992.00
Stockholders' Equity
Common Stock0.000.000.020.000.00
Retained Earnings-69.04-63.91-59.40-32.66-20.22
Accumulated Other Comprehensive Income-0.830.700.16-0.020.00
Additional Paid-in Capital93.3584.4280.8432.790.00
Shares Outstanding2.580.010.010.000.00
Total Stockholders' Equity23.5021.2121.630.21-0.95
Total Liabilities & Equity30.5627.3529.242.200.00